Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tim R Wagner"'
Autor:
Sebastian Uhrig, Carsten Müller-Tidow, Stefan Fröhling, Hartmut Goldschmidt, Michael Platten, Michael Hundemer, Niklas Kehl, Michael Kilian, Julius Michel, Tim R Wagner, Alexander Brobeil, Lilli-Sophie Sester, Sven Blobner, Simon Steiger, Niels Weinhold, Karsten Rippe, Stefan B Eichmüller, Lukas Bunse, Marc-Steffen Raab, Mirco J Friedrich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Multiple myeloma (MM) is a hematological malignancy originating from malignant and clonally expanding plasma cells. MM can be molecularly stratified, and its clonal evolution deciphered based on the Ig heavy and light chains of the respective maligna
Externí odkaz:
https://doaj.org/article/f0969d97b65c4cd4b532d155f2790750
Autor:
Tim R. Wagner, Eren Boğa, Patrick Schmidt, Wolfram Osen, Michael Platten, Hartmut Goldschmidt, Marc S. Raab, Mirco J. Friedrich, Stefan B. Eichmüller
Publikováno v:
Cancer Research. 83:4071-4071
Innovative immunotherapy approaches such as adoptive transfer of chimeric antigen receptor (CAR) T cells or tumor infiltrating lymphocytes (TILs) have shown great success in the treatment of solid tumors and hematological malignancies. Although treat
Autor:
Niklas Kehl, Michael Kilian, Julius Michel, Tim R Wagner, Sebastian Uhrig, Alexander Brobeil, Lilli-Sophie Sester, Sven Blobner, Simon Steiger, Michael Hundemer, Niels Weinhold, Karsten Rippe, Stefan Fröhling, Stefan B Eichmüller, Lukas Bunse, Carsten Müller-Tidow, Hartmut Goldschmidt, Michael Platten, Marc-Steffen Raab, Mirco J Friedrich
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005815
Multiple myeloma (MM) is a hematological malignancy originating from malignant and clonally expanding plasma cells. MM can be molecularly stratified, and its clonal evolution deciphered based on the Ig heavy and light chains of the respective maligna
Autor:
Harald Kolmar, Sebastian Jäger, Tim R. Wagner, Stefan Hecht, Christian Schröter, Nicolas Rasche
Publikováno v:
Bioconjugate chemistry. 32(8)
Fragment crystallizable (Fc) antigen binding fragments (Fcabs) represent a novel antibody format comprising a homodimeric Fc region with an engineered antigen binding site. In contrast to their full-length antibody offspring, Fcabs combine Fc-domain-